Cyclo Therapeutics, Inc. is dedicated to developing biopharmaceutical treatments derived from cyclodextrin to combat various illnesses. A central component of their research and development pipeline is Trappsol Cyclo, a therapeutic specifically targeting Niemann-Pick Type C disease and Alzheimer's disease. Charles E. Rick Strattan founded the company on August 9, 1990, and it is presently based in Gainesville, Florida.
